Alnylam Pharmaceuticals(ALNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALNY Alnylam Pharmaceuticals

Trading 10-15 14:49:53 EDT

231.41

+6.94

+3.09%

High234.00	Low228.12	Vol815.51K
Open230.00	D1 Closing224.47	Amplitude2.62%
Mkt Cap30.88B	Tradable Cap30.81B	Total Shares133.43M
T/O188.70M	T/O Rate0.61%	Tradable Shares133.16M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALNY","market":"US","secType":"STK","nameCN":"Alnylam Pharmaceuticals","latestPrice":231.41,"timestamp":1792090189486,"preClose":224.47,"halted":0,"volume":815506,"delay":0,"changeRate":0.030917271795785618,"floatShares":133157589,"shares":133427910,"eps":5.619342,"marketStatus":"Trading","change":6.94,"latestTime":"10-15 14:49:53 EDT","open":230,"high":234,"low":228.12,"amount":188696761.02166,"amplitude":0.026195,"askPrice":231.54,"askSize":24,"bidPrice":231.24,"bidSize":80,"shortable":3,"etf":0,"ttmEps":5.619342,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792094400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1085630400000,"exchange":"NASDAQ","adjPreClose":224.47,"preHourTrading":{"tag":"盘前","latestPrice":228.686,"preClose":224.47,"latestTime":"09:29 EDT","volume":326,"amount":74924.11382,"timestamp":1792070999998,"change":4.216,"changeRate":0.018782,"amplitude":0.044387},"postHourTrading":{"tag":"盘后","latestPrice":226.36,"preClose":224.47,"latestTime":"19:59 EDT","volume":14270,"amount":3203528.176,"timestamp":1792022385919,"change":1.89,"changeRate":0.00842,"amplitude":0.00842},"volumeRatio":0.846195,"impliedVol":0.6005,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/ALNY","defaultTab":"news","newsList":[{"id":"2675753323","title":"UBS Adjusts Alnylam Pharmaceuticals Price Target to $354 From $550, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2675753323","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675753323?lang=en_us&edition=fundamental","pubTime":"2026-10-15 22:33","pubTimestamp":1792074792,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals (ALNY) has an average rating of overweight and mean price target of $373.81, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675958104","title":"Alnylam Announces Third-Quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2675958104","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675958104?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:00","pubTimestamp":1792065631,"startTime":"0","endTime":"0","summary":"Alnylam Announces Third-Quarter Results Conference CallAlnylam Pharmaceuticals will release results for the quarter ending Sept. 30, 2026, on Oct. 29, 2026, before U.S. markets open.Management will di","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDLXXxVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","PBE","BK4139","LU0882574055.USD","LU0109394709.USD","ALNY","BK4588","BK4548","BK4585","GNMX","LU0320765992.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675376853","title":"Alnylam assumed with a Buy at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675376853?lang=en_us&edition=fundamental","pubTime":"2026-10-15 08:40","pubTimestamp":1792024812,"startTime":"0","endTime":"0","summary":"UBS analyst Joon Lee assumed coverage of Alnylam (ALNY) with a Buy rating with a price target of $354, down from $550. The firm states that its bul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-assumed-with-a-buy-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-assumed-with-a-buy-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4548","LU0320765992.SGD","BK4585","LU0889565916.HKD","BK4139","LU0882574055.USD","LU0114720955.EUR","LU0109394709.USD","PBE","GNMX","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675373229","title":"Alnylam Pharma (ALNY) Receives a New Rating from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2675373229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675373229?lang=en_us&edition=fundamental","pubTime":"2026-10-15 07:56","pubTimestamp":1792022203,"startTime":"0","endTime":"0","summary":"Alnylam Pharma received a Buy rating and a $354.00 price target from Truist Financial analyst Joon Lee today. Lee covers the Healthcare sector, foc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-receives-a-new-rating-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-receives-a-new-rating-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675343273","title":"Alnylam Pharmaceuticals, Inc. : Wells Fargo Cuts Target Price to $253 from $256","url":"https://stock-news.laohu8.com/highlight/detail?id=2675343273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675343273?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:39","pubTimestamp":1791974347,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nAZN4TOWQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BK4139","LU0114720955.EUR","BK4585","LU0320765992.SGD","LU0889565916.HKD","ALNY","PBE","LU0882574055.USD","BK4588","GNMX","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674844386","title":"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674844386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674844386?lang=en_us&edition=fundamental","pubTime":"2026-10-12 07:20","pubTimestamp":1791760808,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Alnylam Pharma (ALNY) and Solventum Corporation (SOLV) with neutral ratings, indicating that the expe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-solventum-corporation-solv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-solventum-corporation-solv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","LU0109394709.USD","LU0128526141.USD","ALNY","GNMX","PBE","XLV","BK4581","BK4585","BK4548","BK4139","BK4198","LU0029874061.USD","BK4588","LU0114720955.EUR","HCSG","LU0882574055.USD","LU0320765992.SGD","LU0889565916.HKD","SOLV","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674134851","title":"BofA Securities Adjusts Alnylam Pharmaceuticals Price Target to $336 From $346","url":"https://stock-news.laohu8.com/highlight/detail?id=2674134851","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674134851?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:17","pubTimestamp":1791548259,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals (ALNY) has an average rating of overweight and mean price target of $373.81, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673907263","title":"Alnylam Pharmaceuticals (ALNY) Is Under Securities Fraud Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673907263","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673907263?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459030,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals (NasdaqGS:ALNY) faces an ongoing securities fraud investigation following a downward revision to its 2026 sales guidance.\nInvestigators are examining whether management disclosures around the updated full year 2026 outlook accurately reflected the business conditions at the time.\nThe probe focuses on potential gaps between prior public commentary on future sales expectations and the revised guidance now presented to investors.\nThe securities fraud investigation tied...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-is-under-securities-fraud-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-is-under-securities-fraud-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GNMX","LU0109394709.USD","LU0882574055.USD","BK4548","LU0320765992.SGD","LU0889565916.HKD","BK4585","LU0114720955.EUR","ALNY","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673965071","title":"RBC Lowers Price Target on Alnylam Pharmaceuticals to $345 From $350, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2673965071","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673965071?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:29","pubTimestamp":1791458954,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals (ALNY) has an average rating of overweight and mean price target of $373.81, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672450627","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-02","url":"https://stock-news.laohu8.com/highlight/detail?id=2672450627","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672450627?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:45","pubTimestamp":1790966707,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-10-02Nasdaq 100.NDXTop PerformersPercent ChangeTeradyne, Inc.TER.OQ+8.2%Space Exploration Technologies CorpSPCX.OQ+7.5%Monolithic Power Systems IncMPWR.OQ+5.5%ARM Holdings PLCARM.OQ+4.9%Tesla IncTSLA.OQ+4.7%Bottom PerformersPercent ChangeSeagate Technology Holdings PLCSTX.OQ-10.8%Western Digital CorpWDC.OQ-10.2%Alnylam Pharmaceuticals, Inc.ALNY.OQ-4.0%SanDisk CorporationSNDK.OQ-3.8%AppLovin CorporationAPP.OQ-3.5%The Nasdaq 100.NDXgained 283.70 points, or 0.93%, to 30,785.72 and recorded 6 new highs and 3 new lows. 61 stocks rose and 40 fell as advancing issues outnumbered decliners by a about a 1.5-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL8N45O1NA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1435385759.SGD","IE00BD6J9T35.USD","CRSH","LU2168564149.EUR","LU2023250330.USD","CNEQ","HK0000914660.USD","LU0689472784.USD","LU1861220033.SGD","LU1066053197.SGD","IE00BKPKM429.USD","TSLQ","LU0957808578.USD","LU2471134523.USD","RULE","TESL","LU1670627923.USD","LU0823411888.USD","SNDK","LU2462157665.USD","LU0476273544.USD","TSLA","IE00B19Z9P08.USD","LU0203345920.USD","BK4141","LU0077335932.USD","BK4555","CGGO","LU1629891620.HKD","LU1066051225.USD","LU2750360641.GBP","LU2250418816.HKD","MPWX","LU2322448791.USD","TSLO","LU0345769128.USD","BK4550","BK4534","TRFK","LU0109394709.USD","LU1046421795.USD","BK4548","07366","LU2471134796.USD","IE00BQXX3D17.EUR","LU2602419157.SGD","SPCF","LU2931357623.SGD","SPCH","TER","ELOL","LU0320765059.SGD","LU2473716301.USD","YSPC","LU1642822529.SGD","LU2087625088.SGD","BK4592","LU0672654240.SGD","LU0444971666.USD","LU1823568750.SGD","SPCQ","IE00BMPRXN33.USD","SNDU","WLDR","TEST","IE0034235303.USD","LU2543165471.USD","LU2750360997.AUD","STSLAmain","IE00BMPRXQ63.HKD","IE00BQXX3C00.GBP","LOFD","LU0943347566.SGD","LU0203347892.USD","LU2322448957.HKD","TSLG","07766","SG9999014005.SGD","BK4608","LU0082616367.USD","SPAL","STX","TSLR","TSLZ","APP","LU0323591593.USD","ARMU","LU1232071149.USD","STXL","LU2210150020.SGD","BK4170","LU1035773651.USD","TSL","FSMD","IE00B894F039.SGD","LU0234570918.USD","SCHM","LU2360107168.USD","LU0353189680.USD","IE00BWXC8680.SGD","LU0081259029.USD","LU2095319765.USD","IE00BN0W2V16.EUR","TSLS","IE00BSNM7G36.USD","LU1852331112.SGD","09766","BK4112","LU1670628061.USD","LU0240878834.USD","LU1992135399.USD","BK4511","CNAV","IE00B64PRP62.GBP","TSLI","LU0963586101.USD","LU1861215975.USD","LU1674673691.USD","IE00B1BXHZ80.USD","LU0240877869.USD","LU0708995401.HKD","LU1551013342.USD","EPAI","SPCG","LU0320765992.SGD","LU2272731600.USD","IE00BN0W2T93.GBP","LU1815336760.USD","SPCX","LU0466842654.USD","LU0353189763.USD","LU0097036916.USD","BK4139","SMOG","LU0444973449.USD","LU0154236417.USD","BK4533","TSLW","QQQA","DISK","SPCU","LU1983260115.SGD","COWG","LU0964807845.USD","BK4604","09366","BK4023","SG9999014021.USD","BK4539","OPTZ","SNDG","SG9999014013.SGD","SPRX","BK4527","LU2456880835.USD","QQQG","MPWR","TSLP","IE00B19Z8W00.USD","IE00BMPRXR70.SGD","TESC","TERG","LU1267930730.SGD","LU1861559042.SGD","IE00BZ9MQY76.HKD","BK4089","FDRV","WANT","LU1066051498.USD","BK4551","IE00BQXX3F31.USD","LU2168564065.EUR","MARS","LU0345770308.USD","SNK","LU2213496289.HKD","LU2108987350.USD","DSPC","LU2357305700.SGD","IE00B19Z9505.USD","LU2471134879.HKD","BCDF","IE00BN0W2W23.USD","LU2272731782.SGD","SNDQ","LU0266013472.USD","LU2087621335.USD","TSII","TSYY","STXX","NDAQ","LU1861558580.USD","FDTX","STXU","LU0820561909.HKD","LU0882574055.USD","LU2420271590.USD","BK4512","LU1992135472.HKD","LU2089985449.USD","LU1548497426.USD","LU0234572021.USD","FCUS","SNDC","WATS","LU0162691827.USD","IE00BGHQF748.EUR","LU2326559502.SGD","SPAX","LU0345770993.USD","LU2168563687.JPY","LU0109391861.USD","IE00BJLML261.HKD","APPX","SSPC","APPC","LU0823414478.USD","ARMW","LU0274383776.USD","TSLL","XDAT","DRMY","TERC","LU2417539215.USD","AIPI","LU0198837287.USD","PTF","LIT","LU2168564222.USD","ALNY","GNMX","CLOD","LU2360106780.USD","TSLT","GB00BDT5M118.USD","IE00B19Z8X17.USD","SG9999015986.USD","LU0053666078.USD","ORBX","LU1429558221.USD","LU0133085943.USD","SCHA","WSPC","LU1914381329.SGD","SPCM","LU2471134952.CNY","LU0345769631.USD","BK4612","LU1720051017.SGD","LU2168564495.EUR","SNXX","BK4585","BK4516","BK4598","LU1551013425.SGD","LU1720051108.HKD","LU1778281490.HKD","BK4613","LU2249611893.SGD","TSDD","LU1066051811.HKD","BK4147","TLA","IE00B1XK9C88.USD","LU0056508442.USD","BK4574","LU2290526834.HKD","EGGY","LU2756315664.SGD","LU1069347547.HKD","LU2210149790.SGD","LU2756315318.SGD","SG9999015952.SGD","LU2236285917.USD","IE00BK4W5M84.HKD","LU0314104364.USD","BK4543","LU0054578231.USD","LU0006061336.USD","TMSL","WDC","HK0000914686.HKD","BK4009","LU0719512351.SGD","LU0114720955.EUR","SG9999015945.SGD","LU0210536198.USD","BK4588","LU1145028129.USD","ARM","LU2896262040.SGD","WDCC","BK4609","LU1235294995.USD","SG9999015978.USD","IE00B19Z9Z06.USD","LU0316494557.USD","WDCX","LU0820562030.AUD","IE00BK4W5L77.USD","LU1674673428.USD","LU2063271972.USD","ARMA","LOFF","LU2403377893.USD","LU1839511570.USD","LU0889565916.HKD","LU0072461881.USD","LU0348723411.USD","TSLY","BK4099","WARP","LU1366192091.USD","MPWC","IE00B3QW5Z07.USD","LU2272731865.HKD","ARMG","SG9999014039.USD","BK4581","IDRV","PBE","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672276152","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01","url":"https://stock-news.laohu8.com/highlight/detail?id=2672276152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672276152?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:45","pubTimestamp":1790880306,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-10-01Nasdaq 100.NDXTop PerformersPercent ChangeSynopsys, Inc.SNPS.OQ+12.9%Lumentum Holdings Inc.LITE.OQ+7.1%Cadence Desig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL8N45N1VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0444971666.USD","LU0289739699.SGD","LU0057025933.USD","LU0353189680.USD","LU2468319806.SGD","MSTU","IE0004445239.USD","IE0034235188.USD","IE00B4R5TH58.HKD","SG9999013999.USD","LU2125909759.SGD","LU2210149790.SGD","LITX","LU0390134368.USD","LU2417539215.USD","LU1674673428.USD","LU0289960550.SGD","LU1623119135.USD","LU2210150020.SGD","QLD","LU1854103824.USD","03455","IE00B0169N27.USD","IE0002141913.USD","LU2095319765.USD","AMGN","LU0889565916.HKD","SGXZ23171101.USD","LU0058720904.USD","04332","LU0354030511.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU2506951792.HKD","LU2360107671.USD","LU2324357040.USD","LU1061106388.HKD","LU1868837722.USD","IE00B19Z9P08.USD","LU0719512351.SGD",".HXC","CRPT","IE00BGV7N243.SGD","LU0210535034.USD","BK4533","LU1803068979.SGD","LU2764263039.SGD","LU1989764748.USD","SNPX","07799","LU1303367103.USD","3SMI.UK","LU1093756325.SGD","IE00BQXX3F31.USD","SG9999000418.SGD","LU2456880835.USD","LU2362541513.USD","LU1585245621.USD","LU0240878834.USD","IE00B19Z3581.USD","LU2087625088.SGD","LU2098885051.SGD","LU2764263203.CNY","MSTW","LU0069063385.USD","LU2125909593.SGD","PJP","LU2360106780.USD","BK4548","IE00B8L5B284.USD","LU1868838027.USD","LU1815333072.USD","LITZ","SG9999004303.SGD","LU0348723411.USD","IE00BQXX3D17.EUR","LU1923622291.USD","QID","LU0124384867.USD","PBE","KMLI","SQQQ","APPX","LU1852331112.SGD","QQQX","SG9999001176.SGD","BK4613","LU2211814178.USD","LU2237438978.USD","BITQ","LU0342679015.USD","LU1861219969.SGD","09834","BK4566","LU2360107325.USD","LU0456842615.SGD","LU2506952337.HKD","ONLN","07266","PSQ","LITG","IE00BQXX3C00.GBP","BK4139","LU2249611893.SGD","GPIQ","QMAR","BK4588","LU1712237335.SGD","BK4539","IMST","LU1989764664.SGD","BK4220","QDEC","03086","LU2236285917.USD","07522","LU0256863811.USD","OWNB","LU2298322129.HKD","BK4023","LU2355687059.USD","IE0002270589.USD","LU0312595415.SGD","LU0266013472.USD","MSTK","APED","VRTX","BK4581","BIB","MSDD","LU2290526834.HKD","QQQ","LU0354030438.USD","LU2543165471.USD","LU2362540622.SGD","LU0106959298.USD","NDX","PRNT","SNPS","LU0061474960.USD","LU0082616367.USD","LU0823414551.USD","LU0175139822.USD","IE00BJT1NW94.SGD","TBXU","IBB","LU1323610961.USD","LU0109394709.USD","LU1815336760.USD","NJAN","BK4206","LU0061475181.USD","LU0097036916.USD","02834","FOTO","LU0012050646.USD","LU0724618433.USD","LU2265009873.SGD","LU2125909916.SGD","TQQQ","BK4534","LU0154236417.USD","LU0053687314.USD","LU0106261612.USD","MSTC","XDAT","LU2089984988.USD","LU0289961442.SGD","IE00BZ199S13.USD","MSST","LU1778281490.HKD","SMST","07399","LU1861220033.SGD","BK4543","LU0532187761.SGD","LU0094547139.USD","WNTR","LU1923622614.USD","IE00B0JY6N72.USD","LU1093756168.USD","LU2247934214.USD","07568","LU1861217088.USD","09799","LU2112291526.USD","SMI3.UK","SG9999001176.USD","BBH","LU0114720955.EUR","BK4599","LU0143863784.USD","LU1804176565.USD","BK4600","LU2242646821.SGD","MSTX","LU1035775433.USD","IE0009355771.USD","CDNG","LU0823417653.USD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","LU0056508442.USD","LU0511384066.AUD","LU2764262908.HKD","LU1721428347.USD","IE00B894F039.SGD","EGGY","LU0079474960.USD","LU0205194284.USD","LITE","BK4122","MSTR","BK4596","MSTZ","LU1868837565.USD","BK4595","IE0008368304.USD","LU0347712357.USD","LU1721428933.USD","MSTY.UK","LU0552385451.USD","MSOO","NJUL","MSII","LUMA","IE00BN0W2W23.USD","LU0109392836.USD","LU1861214812.USD","LAZR","LU1633808545.USD","BK4516","BK4020","LU1069344957.HKD","LMI3.UK","LU2362541273.HKD","07261","LU0289739343.SGD","LU0957791311.USD","IDNA","LU0323240290.USD","LU0472753341.HKD","LU0417517546.SGD","LU2063271972.USD","LU2506952170.USD","LU2242652126.USD","QQQM","LU1951198990.SGD","TQQY","LU0431992006.USD","LU2458330169.SGD","LU2433249047.HKD","LU2477742899.HKD","LU2720916845.USD","LU0868486357.SGD","LU1978683503.SGD","LU0122379950.USD","ALNY","LITU","APP","LU0302445910.USD","GNMX",".IXIC","MELI","LU2413666426.HKD","LU1571399168.USD","MSTP","BK4567","IE00BD6J9T35.USD","LU0950375773.USD","LU2413666699.HKD","GB00BDT5M118.USD","LU2250418816.HKD","LU0240877869.USD","LU2294711713.HKD","LU2279701549.SGD","BK4532","LU1861220207.SGD","IE00BN0W2V16.EUR","LU2458330243.SGD","LU1854104046.USD","LU0728928796.USD","LU2360107168.USD","NOCT","BK4009","LU1923623000.USD","LU0096362180.USD","LU2506952410.USD","LITC","IE0009356076.USD","LU0823411888.USD","IE00B1B80R65.USD","LU2506951958.HKD","SG9999001440.SGD","3LMI.UK","LU0107464264.USD","LU2211815571.USD","MTYY","SGXZ51526630.SGD","LU0868494617.USD","LU0957808578.USD","SGXZ99366536.SGD","IE00B8HQ1Z84.USD","LU0823417737.USD","IE00BKPKM429.USD","BK4608","LU1821325948.USD","CLOD","IE00BN0W2T93.GBP","LU0205193047.USD","ROP","LU2506952097.USD","IE00B19Z3B42.SGD","IBBQ","IE00B5949003.HKD","LU0323239441.USD","IE00BZ9MQY76.HKD","LU0170899867.USD","MST","LU2506951875.HKD","LU0143863198.USD","LU2125909247.SGD","09086","LU1642822529.SGD","NAPR","IE00B2B36J28.USD","LU1951200564.SGD","LU0050427557.USD","APPC","LU1023059063.AUD","LU2097829019.USD","LU0786609619.USD","LU0353189763.USD","09399","LU2462157665.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1983299246.USD","LU2275660780.HKD","LU1430594728.SGD","LU0823414478.USD","LU1057294990.SGD","LU1674673691.USD","03034","LU0889565833.HKD","CDNS","LU0823416689.USD","LU1861215975.USD","LU0320765992.SGD","MSTY","LU0882574055.USD","BK4585","LU2357125470.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107696121","title":"Movement Alert｜Alnylam Pharmaceuticals Falls 5.13% in Regular Trading, Multiple Banks Cut Price Targets Pressuring Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1107696121","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107696121?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:20","pubTimestamp":1790868043,"startTime":"0","endTime":"0","summary":"On October 1, Alnylam Pharmaceuticals fell 5.13% in regular trading, trading at $234.2 per share with turnover of $152 million. The decline comes amid a wave of investment bank price target...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alnylam Slips as JPMorgan Cuts Target to $369","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203212","title":"Compass Pathways Names Kelley Boucher Chief People Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203212","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203212?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:30","pubTimestamp":1790764240,"startTime":"0","endTime":"0","summary":"Compass Pathways names Kelley Boucher chief people officerCompass Pathways appointed Kelley Boucher as chief people officer, effective today.Role includes oversight of people strategy as the company s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL7zWWlC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","BK4548","IE00B19Z9Z06.USD","LU0109394709.USD","BK4139","LU0234570918.USD","PBE","CMPS","BK4585","GNMX","LU0320765992.SGD","BK4532","BIIB","BK4533","ALNY","BK4588","PSIL","LU0882574055.USD","IE00B894F039.SGD","IE00B19Z9P08.USD","BMED","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671279309","title":"US Research Roundup-Alnylam Pharmaceuticals, Carvana, MongoDB","url":"https://stock-news.laohu8.com/highlight/detail?id=2671279309","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671279309?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:35","pubTimestamp":1790753728,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDBSept 30 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Alnylam","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCL","COHR","GNRC","AEE","IMMX","ANET","CIEN","GAMR","EFIV","JAZZ","SPRX","CCL","HNGE","CVNA","MRNX","HUN","SKYY","KMX","FSLR","ALNY","BRO","GLW","IOND","GSHD","MRNA","AIR","ACHV","CC","MSFD","GPK","AJG","EGGY","MRSH","ANNX","EMN","MSFO","MSFT","CE","DOW","BCRX","AMPL","LITE","ANAB","MDB","HAWK","BBUC","CSCO","CSCS","LW","DYN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471236","title":"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471236?lang=en_us&edition=fundamental","pubTime":"2026-09-26 21:00","pubTimestamp":1790427637,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY) and Revvity (RVTY). Alnylam ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-revvity-rvty-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-revvity-rvty-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0882574055.USD","BK4585","BK4139","IE00BLDYK493.USD","BK4121","LU0889565916.HKD","GNMX","LU0054578231.USD","BK4548","LU0029874061.USD","IE00BN0W2T93.GBP","LU0114720955.EUR","RVTY","IE00BN0W2W23.USD","XLV","XBI","BK4588","ALNY","IE00BN0W2V16.EUR","IE00B64QTZ34.USD","LABU","HCSG","BK4581","LU0320765992.SGD","LU0128526141.USD","PBE","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157709","title":"Alnylam Pharmaceuticals Price Target Maintained with a $455.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157709","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157709?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:44","pubTimestamp":1789987440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150936","title":"Analysts Offer Insights on Healthcare Companies: Innate Pharma (IPHA) and Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150936","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150936?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:40","pubTimestamp":1789987218,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Innate Pharma (IPHA) and Alnylam Pharma (ALNY) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-innate-pharma-ipha-and-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-innate-pharma-ipha-and-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","HCSG","IPHA","LABU","LU0889565916.HKD","BK4548","LU0114720955.EUR","LU0320765992.SGD","GNMX","LU0029874061.USD","BK4588","PBE","XLV","BK4585","XBI","LU0882574055.USD","BK4581","LU0109394709.USD","BK4139","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667078256","title":"Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667078256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667078256?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:30","pubTimestamp":1789554624,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alnylam-pharma-alny-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alnylam-pharma-alny-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0320765992.SGD","BK4139","LU0889565916.HKD","BK4137","LU0109394709.USD","LU0114720955.EUR","ALNY","LU0029874061.USD","LU0128526141.USD","HCSG","IBRN","THNR","LU0882574055.USD","GNMX","XBI","PBE","BK4585","XLV","LABU","BK4581","BK4548","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667234796","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2667234796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667234796?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:01","pubTimestamp":1789484480,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-09-15Nasdaq 100.NDXTop PerformersPercent ChangeQUALCOMM IncorporatedQCOM.OQ+3.4%ARM Holdings PLCARM.OQ+3.1%Marvell Techno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL8N457167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046421795.USD","QQQG","LU1992135472.HKD","IE0004445239.USD","MSTY.UK","LU1267930730.SGD","LU1066051225.USD","LU0114720955.EUR","IE00BSNM7G36.USD","IE00B1B80R65.USD","MSOO","LU1983260115.SGD","MVLL","AIPI","LU0708995401.HKD","LU1989772923.USD","LU0957808578.USD","IE00B0169N27.USD","SQCOMmain","WUGI","IETC","STX","LU2272731782.SGD","03086","LU2361045086.USD",".HXC","LU1974910355.USD","LU2097829019.USD","LU0823411888.USD","MSTR","AMD","LU0882574055.USD","LU0942090050.USD","LU2322448791.USD","KMLI","LU1066051498.USD","BK4141","LU2244417387.USD","IE00B0JY6N72.USD","LU1823568750.SGD","LU1923622291.USD","OILT","LU0048573561.USD","BK4566","LU2108987350.USD","LU0672654240.SGD","NDX","LU0823434583.USD","BK4605","FANG","LU1642822529.SGD","09086","LU0532187761.SGD","LU0251132253.USD","IE00BQXX3D17.EUR","LU0127658192.USD","IE00BQXX3C00.GBP","LU2360107671.USD","IE0001KFT4U8.USD","MSTP","BK4023","LU1720051017.SGD","IE00BKVL7J92.USD","MSDD","LU1923623000.USD","GNMX","LMI3.UK","LU2272731600.USD","BK4527","MRVU","LU0472753341.HKD","LU1670628061.USD","SPRX","BK4534","09834","LU0390134368.USD","LU1861215975.USD","AMDL","MSTU","LU1303367103.USD","LU0786609619.USD","SOXY","LU0175139822.USD","07568","IE00B19Z9P08.USD","XAR","MSTX","LU1235294995.USD","LU1119994496.HKD","BK4585","02834","LU2860962120.EUR","LU1316542783.SGD","03455","MSST","BK4213","LU2247934214.USD","LU1242518931.SGD","LU2461242641.AUD","DTCR","LU2125909916.SGD","LU0203345920.USD","07522","LU0106959298.USD","BK4595","DISK","STXX",".IXIC","MTYY","LU0444973449.USD","LU1861220033.SGD","XNTK","NJAN","IE00B1BXHZ80.USD","LU0143863198.USD","LU1720051108.HKD","LU0109391861.USD","LU0979878070.USD","BK4548","BK4220","LU0251131958.USD","LU0133085943.USD","CHPS","LU1548497426.USD","BK4588","LU2360106780.USD","ALNY","LU2125909759.SGD","IE00BLSP4452.SGD","IE0004091025.USD","MSTZ","LU0109392836.USD","TDV","LU0056508442.USD","AMDW","IE00BGHQF524.EUR","LU1496350502.SGD","LU2462591350.SGD","LU2265009873.SGD","QQQ","BK4543","LU0354030511.USD","LU0889566641.SGD","ARMU","DRMY","LU0552385451.USD","QLD","LU0889565916.HKD","APED","LU0050427557.USD","QDEC","BITQ","GAMR","IE00B5949003.HKD","BK4170","FDTX","BK4532","LU0823421333.USD","IE00BVYPNQ40.USD","LU1804176565.USD","LU0354030438.USD","AMDU","IE00BGV7N243.SGD","IE00BMPRXN33.USD","OWNB","BK4612","LU2272731865.HKD","GB00BDT5M118.USD","QCMU","LU0081259029.USD","BK4512","MRVX","LU2473716301.USD","ARTY","MST","BK4187","BK4581","LU0320765992.SGD","LU2361044865.SGD","ONLN","LU1244550494.USD","LU0187121727.USD","LU2290526834.HKD","SGXZ51526630.SGD","ARMW","IE0004086264.USD","LU1852331112.SGD","BK4554","LU0203347892.USD","LU1880398554.USD","07399","03034","LU0082616367.USD","LU1169590202.USD","GUNZ","AIS","TTEQ","MELI","SG9999002224.SGD","AMYY","LU0431992006.USD","IE00BVYPNP33.GBP","GPIQ","LU0792757196.USD","LU0266013472.USD","SG9999015945.SGD","LU2264538146.SGD","LU1861217088.USD","AMDD","MSTY","LU2098885051.SGD","BK4515","LU1064131342.USD","LU1261432733.SGD","AMDG","MSTC","ARMA","SGXZ81514606.USD","LU0742534661.SGD","LU0143863784.USD","BK4573","IE00BMPRXR70.SGD","AMDY","LEGR","BK4575","QMAR","09799","CHAT","SAMD0main","LU1989764664.SGD","LU2106854487.HKD","WNTR","LU0274383776.USD","STXU","LU1951198990.SGD","LU0320765059.SGD","3LMI.UK","LU2458330243.SGD","LU0289739343.SGD","07266","RULE","QCML","IE00B894F039.SGD","BK4579","SG9999000418.SGD","LU0210536198.USD","LU1244550221.USD","LU1989772840.SGD","3SMI.UK","AXUP","LU0198837287.USD","IE0009356076.USD","LU2896262040.SGD","SOXX","FTXL","LU0476273544.USD","QCMD","LU2211815571.USD","QCOM","LU2023250504.SGD","LU1066053197.SGD","LU2357305700.SGD","MSTW","BK4609","FCUS","LU1066051811.HKD","IE00BBT3K403.USD","IE00B2Q91V27.USD","ARMG","AXON","07261","AMDS","IE00B19Z9Z06.USD","SG9999002232.USD","CNAV","CRPT","07799","EYES","TEXX","SMST","BK4516","LU0444971666.USD","LU0456842615.SGD","STXL","LU0868494708.USD","LU0109394709.USD","IE00B8L5B284.USD","NOCT","SG9999015952.SGD","LU0823421416.USD","SGXZ99366536.SGD","AIFD","BAI","WLDR","LU0868494617.USD","AIQ","LU2063271972.USD","MSII","WISE","IE00BGHQDM52.EUR","LU0174119429.USD","LU0511384066.AUD","MRVL","LU1267930813.SGD","SMI3.UK","LU0069063385.USD","LU1815336760.USD","LU0079474960.USD","HK0000914660.USD","IE00BN8TJ469.HKD","IE00B8HQ1Z84.USD","QQQA","BK4529","LU2355687059.USD","LU1951200564.SGD","AMUU","QQQM","LU0210535034.USD","LU1868837565.USD","MSTK","LU1868838027.USD","LU0719512351.SGD","NAPR","LU1861558580.USD","BK4604","LU1868837722.USD","SG9999015986.USD","IE00B3CCJ963.GBP","LU1084165304.USD","LU2322448957.HKD","LU2543165471.USD","LU1861559042.SGD","LU1861220207.SGD","IE00BLSP4239.USD","PBE","IE00BQXX3F31.USD","LU2417539215.USD","LU1232071149.USD","SMH","BK4598","LU1880398471.USD","SG9999001424.SGD","GTEK","LU2236285917.USD","QQQX","BK4561","BK4600","NJUL","DAMD","LU2456880835.USD","LU0048584097.USD","AMDC","09399","LU0868486357.SGD","IMST","ARM","LU2458330169.SGD","SQQQ","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU1242518857.USD","LU0889565833.HKD","ILDR","USXF","PSQ","LU1069344957.HKD","SMHX","LU1035775433.USD","FAI","LU1169589451.USD","LU0053687314.USD","LU0057025933.USD","LU2089985449.USD","QID","LU0251142724.SGD","LU0823434740.USD","TRFK","LU1988902786.USD","LU2931357623.SGD","TQQY","TQQQ","LU0289961442.SGD","EGGY","LU1670627923.USD","LU0107464264.USD","LU2279701549.SGD","BK4596","LU0642271901.SGD","SG9999015978.USD","LU0289960550.SGD","PSI","BK4122","BK4139","BK4614","LU2361044949.HKD","LU2360107168.USD","LU0348723411.USD","LU1992135399.USD","LU2242649171.HKD","LU1917777945.USD","LU1803068979.SGD","TEK","LU1989764748.USD","LU0154236417.USD","IE00BMPRXQ63.HKD","LU0061475181.USD","FXL","HK0000914686.HKD","LU2054465674.USD","LU2250418816.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665037903","title":"Alnylam Pharmaceuticals Price Target Raised to $260.00/Share from $230.00 by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2665037903","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665037903?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:48","pubTimestamp":1788882480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alnylam.com","stockEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.1021},{"period":"3month","weight":-0.2072},{"period":"6month","weight":-0.2751},{"period":"1year","weight":-0.5218},{"period":"ytd","weight":-0.4355}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0837},{"period":"1year","weight":0.1621},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.028609},{"month":2,"riseRate":0.454545,"avgChangeRate":0.002754},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.012836},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.021744},{"month":5,"riseRate":0.590909,"avgChangeRate":0.038262},{"month":6,"riseRate":0.608696,"avgChangeRate":0.061553},{"month":7,"riseRate":0.652174,"avgChangeRate":0.088481},{"month":8,"riseRate":0.608696,"avgChangeRate":0.042836},{"month":9,"riseRate":0.565217,"avgChangeRate":0.034006},{"month":10,"riseRate":0.391304,"avgChangeRate":-0.044111},{"month":11,"riseRate":0.727273,"avgChangeRate":0.078577},{"month":12,"riseRate":0.454545,"avgChangeRate":0.006257}],"exchange":"NASDAQ","name":"Alnylam Pharmaceuticals","nameEN":"Alnylam Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alnylam Pharmaceuticals(ALNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alnylam Pharmaceuticals(ALNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alnylam Pharmaceuticals,ALNY,Alnylam Pharmaceuticals股票,Alnylam Pharmaceuticals股票老虎,Alnylam Pharmaceuticals股票老虎国际,Alnylam Pharmaceuticals行情,Alnylam Pharmaceuticals股票行情,Alnylam Pharmaceuticals股价,Alnylam Pharmaceuticals股市,Alnylam Pharmaceuticals股票价格,Alnylam Pharmaceuticals股票交易,Alnylam Pharmaceuticals股票购买,Alnylam Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alnylam Pharmaceuticals(ALNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alnylam Pharmaceuticals(ALNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction